Back
Day Range
$23.79
$25.05
52-Week Range
$9.98
$29.65
Volume
1,212,913
50D / 200D Avg
$21.55
/
$17.77
Prev Close
$24.51
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -8.1 | 0.3 |
| P/B | 10.7 | 3.0 |
| ROE % | -97.9 | 3.7 |
| Net Margin % | -20.2 | 3.8 |
| Rev Growth 5Y % | 9.6 | 10.0 |
| D/E | 2.9 | 0.2 |
Analyst Price Target
Hold
$30.50
+25.7%
Low: $21.00
High: $56.00
Forward EPS
-$0.76
Est. Revenue
1.08B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$1.76
$1.70 – $1.84
|
1.64B | 3 |
| FY2029 |
$1.29
$1.25 – $1.35
|
1.53B | 3 |
| FY2028 |
$0.63
$0.39 – $1.27
|
1.36B | 9 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-19 | -$0.09 | -$0.01 | +89.3% |
| 2025-11-06 | -$0.31 | -$0.31 | 0.0% |
| 2025-08-06 | -$0.40 | -$0.48 | -20.0% |
| 2025-04-30 | -$0.60 | -$0.67 | -11.7% |
| 2025-02-26 | -$0.25 | -$0.44 | -76.0% |
| 2024-11-06 | -$0.43 | -$0.36 | +16.3% |
| 2024-08-01 | -$0.54 | -$0.47 | +13.0% |
| 2024-05-02 | -$0.80 | -$0.63 | +21.3% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 9.62% annually over 5 years — modest growth
Debt/Equity of 2.86 — high leverage
Negative free cash flow of -29.67M
Capital efficient — spends only 1.97% of revenue on capex
Growth
Revenue Growth (5Y)
9.62%
Revenue (1Y)7.93%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-97.88%
ROIC-9.77%
Net Margin-20.17%
Op. Margin-7.70%
Safety
Debt / Equity
2.86
Current Ratio2.55
Interest Coverage-9.88
Valuation
P/E Ratio
-8.10
Forward P/EN/A
P/B Ratio10.68
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.93% | Revenue Growth (3Y) | 16.50% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 9.62% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.01B | Net Income (TTM) | -204.71M |
| ROE | -97.88% | ROA | -23.23% |
| Gross Margin | 52.31% | Operating Margin | -7.70% |
| Net Margin | -20.17% | Free Cash Flow (TTM) | -29.67M |
| ROIC | -9.77% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2.86 | Current Ratio | 2.55 |
| Interest Coverage | -9.88 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -8.10 | Forward P/E | N/A |
| P/B Ratio | 10.68 | P/S Ratio | 1.63 |
| PEG Ratio | -0.07 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 1.53 | Fwd Earnings Yield | N/A |
| FCF Yield | -1.79% | ||
| Market Cap | 1.66B | Enterprise Value | 2.01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.01B | 940.20M | 747.72M | 801.22M | 702.80M |
| Net Income | -204.71M | -96.03M | -222.61M | -94.59M | 15.57M |
| EPS (Diluted) | -3.04 | -1.47 | -3.43 | -1.47 | 0.24 |
| Gross Profit | 530.85M | 489.57M | 367.69M | 412.99M | 376.22M |
| Operating Income | -78.12M | -99.13M | -233.23M | -92.85M | 22.65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 881.11M | 967.66M | 952.66M | 1.05B | 905.14M |
| Total Liabilities | 725.94M | 704.56M | 639.03M | 612.84M | 472.03M |
| Shareholders' Equity | 155.17M | 263.10M | 313.63M | 439.95M | 433.11M |
| Total Debt | 444.48M | 473.57M | 415.67M | 419.88M | 314.67M |
| Cash & Equivalents | 90.63M | 69.23M | 58.87M | 172.52M | 71.18M |
| Current Assets | 618.14M | 724.49M | 747.99M | 849.98M | 811.52M |
| Current Liabilities | 242.72M | 247.05M | 195.26M | 165.29M | 131.86M |